Remove 2013 Remove Clinic Remove Radiation
article thumbnail

Radiation Oncology Physician Groups Unite to Ensure Patient Access to Cancer Care

Imaging Technology

milla1cf Tue, 01/30/2024 - 19:43 January 30, 2024 — The largest professional societies representing radiation oncology physicians in the United States announced a partnership with the goal of reforming radiation oncology Medicare payments to expand and enhance access to high quality care for people with cancer. ASTRO Chair Jeff M.

article thumbnail

Radiation oncology groups unite to reform Medicare payments

AuntMinnie

physician groups representing radiation oncology have partnered to try to reform Medicare payments and expand patient access to high-quality care. In other news, ASTRO said that chief executive officer Laura Thevenot plans to retire at the end of 2024 after leading the organization since 2002.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medicare Physician Payment Final Rule Cements More Cuts to Radiation Oncology, Underscores Need for Legislative Fix

Imaging Technology

milla1cf Fri, 11/03/2023 - 12:20 November 3, 2023 —The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M. The consistent decline in Medicare reimbursement for radiation oncology threatens to undermine patients’ access to vital cancer care across the country. 2474), introduced by Reps.

article thumbnail

ASTRO Urges Legislative Action as Reimbursement Cuts Continue in Proposed FY25 MPFS

Imaging Technology

mtaschetta-millane Thu, 07/11/2024 - 08:52 July 11, 2024 — The American Society for Radiation Oncology ( ASTRO ) issued the following statement from Jeff M. Since 2013, CMS has cut radiation oncology reimbursement through the MPFS by more than 20%, more than nearly any other medical specialty. and Gary Peters (D-Mich.),

article thumbnail

ASTRO chair responds to proposed cuts in 2024 MPFS

AuntMinnie

The American Society for Radiation Oncology (ASTRO) has issued a statement from Jeff Michalski, MD, chair of the ASTRO board of directors, in response to continued reimbursement declines in the proposed 2025 Medicare Physician Fee Schedule (MPFS). 8404), introduced in the House of Representatives and Senate in May.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

article thumbnail

Treatment paradigm shifting for men with prostate cancer

AuntMinnie

They are cancer cell-targeting molecules injected into the body that travel to tumor sites and release radiation that destroys the DNA of cancer cells. Radionuclides such as Pluvicto and Xofigo represent the most advanced treatments to date. If you decide to use Xofigo first, you can then use Pluvicto. Now there’s Pluvicto, she said.